Brandywine Global Investment Management, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 90 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brandywine Global Investment Management, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q4 2022$1,347,682
+78.5%
318,6010.0%0.01%
+57.1%
Q3 2022$755,000
-19.9%
318,601
-3.6%
0.01%
-12.5%
Q2 2022$942,000
-13.9%
330,500
-13.0%
0.01%0.0%
Q1 2022$1,094,000
-5.3%
380,0000.0%0.01%0.0%
Q4 2021$1,155,000380,0000.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders